Filters

See more specimen types...

Other countries

Results: 1 to 20 of 36 (representing 14 labs)

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7861205
  • C Sequence analysis of the entire coding region

Spastic paraplegia 17, autosomal dominant

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Spastic Paraplegia Comprehensive Sequencing Panel

PreventionGenetics
United States
4861
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Complex Hereditary Spastic Paraplegia Sequencing Panel

PreventionGenetics
United States
4353
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Distal Hereditary Motor Neuropathy Sequencing Panel

PreventionGenetics
United States
2820
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Seipin-Related Disorders via the BSCL2 Gene

PreventionGenetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Spastic paraplegia panel, autosomal dominant

LifeLabs Genetics
Canada
1313
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Spastic Paraplegia Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
8658
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HSP, Complete Dominant Evaluation

Athena Diagnostics Inc
United States
1710
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HSP, Supplemental Sporadic Evaluation

Athena Diagnostics Inc
United States
2422
  • C Sequence analysis of the entire coding region

HSP, Comprehensive Evaluation

Athena Diagnostics Inc
United States
4024
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HSP, Supplemental Dominant Evaluation

Athena Diagnostics Inc
United States
126
  • C Sequence analysis of the entire coding region

Hereditary spastic paraplegia (HSP), autosomal dominant and X-linked Panel

CeGaT GmbH
Germany
2217
  • C Sequence analysis of the entire coding region

SPASTIC PARAPLEGIA A.D.

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1010
  • C Sequence analysis of the entire coding region

Hereditary Spastic Paraplegia

Asper Biotech Asper Biotech Ltd.
Estonia
3434
  • C Sequence analysis of the entire coding region

Invitae Hereditary Spastic Paraplegia Autosomal Dominant Panel

Invitae
United States
1616
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary spastic paraplegia (NGS panel for 43 genes)

CGC Genetics
Portugal
4043
  • C Sequence analysis of the entire coding region

Hereditary distal motor neuropathy type VA (sequence analysis of BSCL2 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Single gene testing BSCL2

CeGaT GmbH
Germany
41
  • C Sequence analysis of the entire coding region

Spinal Muscular Atrophy (SMA) Panel

CeGaT GmbH
Germany
4427
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 36

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center